Tucker Kelly

Tucker Kelly

Director of Finance/CFO at XENON PHARMACEUTICALS INC.

Net worth: - $ as of 31/05/2026

55 year
Health Technology
Finance
Commercial Services

Profile

Thomas P.
Kelly
is currently Chief Financial Officer at Xenon Pharmaceuticals, Inc. since 2025.
Formerly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. from 2015 to 2019, Chief Financial Officer at AdvanDx, Inc. from 2012 to 2015, Chief Financial Officer at deCODE Genetics ehf from 2010 to 2011, Chief Financial Officer and SVP-Finance & Corporate Development at Critical Therapeutics, Inc. from 2007 to 2008, Principal at Canaccord Adams, Inc. from 2003 to 2007, Vice President-Life Sciences Investment Banking at Robertson Stephens, Inc. from 1998 to 2002, and Associate at Foley Hoag LLP from 1996 to 1998.
Education includes graduate studies at The University of Chicago Law School and undergraduate studies at Edmund A. Walsh School of Foreign Service.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/10/2025 0 ( -.--% ) - $ 31/05/2026

Tucker Kelly active positions

CompaniesPositionStart
XENON PHARMACEUTICALS INC. Director of Finance/CFO 15/10/2025

Former positions of Tucker Kelly

CompaniesPositionEnd
Director of Finance/CFO 16/03/2015
Director of Finance/CFO 01/01/2011
Director of Finance/CFO 04/11/2008
Corporate Officer/Principal 01/08/2007
Corporate Officer/Principal 01/07/2002
See the detail of Tucker Kelly's experience

Training of Tucker Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

90

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology